MP24-15 CLINICAL UTILITY OF DETECTING LOW-FREQUENCY CELL-FREE DNA VARIANTS IN CASTRATION-RESISTANT PROSTATE CANCER
2021
INTRODUCTION AND OBJECTIVE:Plasma cell-free DNA (cfDNA) testing is emerging as a tool for precision medicine in castration-resistant prostate cancer (CRPC). However, circulating cell-free tumor DNA...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI